Marine Depsipeptide Nobilamide I Inhibits Cancer Cell Motility and Tumorigenicity via Suppressing Epithelial–Mesenchymal Transition and MMP2/9 Expression

• Tu Cam Le,
• Sultan Pulat,
• Jihye Lee,
• Geum Jin Kim,
• Haerin Kim,
• Eun-Young Lee,
• Prima F. Hillman,
• Hyukjae Choi,
• Inho Yang,
• Dong-Chan Oh,
• Hangun Kim,
• Sang-Jip Nam,
• William Fenical

Affiliations

Tu Cam Le

College of Pharmacy, Hong Bang International University, Ho Chi Minh City, Vietnam

Sultan Pulat

College of Pharmacy, Sunchon National University, Sunchon-si, Jeonnam, Republic of Korea

Jihye Lee

Department of Chemistry and Nanoscience, Ewha Womans University, Seoul, Republic of Korea

Geum Jin Kim

College of Pharmacy, Yeungnam University, Gyeongsan-si, Gyeongsangbukdo, Republic of Korea

Haerin Kim

The Graduate School of Industrial Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea

Eun-Young Lee

Department of Chemistry and Nanoscience, Ewha Womans University, Seoul, Republic of Korea

Prima F. Hillman

Department of Chemistry and Nanoscience, Ewha Womans University, Seoul, Republic of Korea

Hyukjae Choi

College of Pharmacy, Yeungnam University, Gyeongsan-si, Gyeongsangbukdo, Republic of Korea

Inho Yang

Department of Convergence Study on the Ocean Science and Technology, Korea Maritime and Ocean University, Busan, Republic of Korea

Dong-Chan Oh

Natural Products Research Institute College of Pharmacy, Seoul National University, Seoul, Republic of Korea

Hangun Kim

College of Pharmacy, Sunchon National University, Sunchon-si, Jeonnam, Republic of Korea

Sang-Jip Nam

Department of Chemistry and Nanoscience, Ewha Womans University, Seoul, Republic of Korea

William Fenical

Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California-San Diego, La Jolla, California, United States